MedTrace Logo

Michigan Genetic Hereditary Testing (MiGHT)

NCT05162846 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 831

Last updated 2026-03-09

No results posted yet for this study

Summary

The primary purpose of this study is to compare three interventions, two experimental and one standard of care (usual care), to see if the experimental interventions will increase the likelihood of a participant obtaining guideline-concordant genetic testing. Eligible participants will be randomized (assigned) to one of the following interventions: 1) Virtual genetics navigator, a mobile-optimized website, designed by the investigators, that delivers tailored messages and content; 2) two motivational interviewing (MI) telephone calls delivered by trained genetics health coaches; or 3) usual care.

Conditions

Interventions

OTHER

Publicly available genetic testing resources

Participants may view the publicly available Michigan Department of Health and Human Services (MDHHS) website as they wish.

BEHAVIORAL

Virtual genetics navigator

A mobile-optimized website/online genetic tool developed by investigators from the University of Michigan's Center for Health Communications Research (CHCR).

BEHAVIORAL

Motivational interviewing (MI)

At least 2 phone calls delivered by trained genetic health coaches using motivational interviewing and providing genetic testing information.

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Michigan Rogel Cancer Center

    lead OTHER

Principal Investigators

  • Elena Stoffel, MD, MPH · University of Michigan Rogel Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-21
Primary Completion
2025-07-13
Completion
2025-11-21

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05162846 on ClinicalTrials.gov